Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device pro… Read more
Shandong Weigao Group Medical Polymer Company Limited (UK2) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.024x
Based on the latest financial reports, Shandong Weigao Group Medical Polymer Company Limited (UK2) has a cash flow conversion efficiency ratio of 0.024x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€558.58 Million) by net assets (€23.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Weigao Group Medical Polymer Company Limited - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Shandong Weigao Group Medical Polymer Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shandong Weigao Group Medical Polymer Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Weigao Group Medical Polymer Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atlas Energy Solutions Inc.
NYSE:AESI
|
0.003x |
|
Gemalto N.V
OTCGREY:GTOFF
|
0.000x |
|
Stadler Rail AG
PINK:SRAIF
|
-0.826x |
|
Primaris Real Estate Investment Trust
PINK:PMREF
|
0.038x |
|
Shanghai Liangxin Electrical Co Ltd
SHE:002706
|
0.042x |
|
Jilin Chemical Fibre Co Ltd
SHE:000420
|
0.011x |
|
MGI Tech Co. Ltd. A
SHG:688114
|
N/A |
|
Nishi-Nippon Railroad Co. Ltd
F:NNR
|
N/A |
Annual Cash Flow Conversion Efficiency for Shandong Weigao Group Medical Polymer Company Limited (2013–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Weigao Group Medical Polymer Company Limited from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €25.34 Billion | €2.79 Billion | 0.110x | -5.61% |
| 2023-12-31 | €23.99 Billion | €2.80 Billion | 0.117x | +23.49% |
| 2022-12-31 | €23.45 Billion | €2.21 Billion | 0.094x | -34.94% |
| 2021-12-31 | €20.91 Billion | €3.04 Billion | 0.145x | -4.25% |
| 2020-12-31 | €18.39 Billion | €2.79 Billion | 0.152x | +10.98% |
| 2019-12-31 | €17.00 Billion | €2.32 Billion | 0.137x | -6.48% |
| 2018-12-31 | €15.19 Billion | €2.22 Billion | 0.146x | +57.46% |
| 2017-12-31 | €13.64 Billion | €1.27 Billion | 0.093x | +7.52% |
| 2016-12-31 | €12.21 Billion | €1.05 Billion | 0.086x | -11.59% |
| 2015-12-31 | €10.79 Billion | €1.05 Billion | 0.098x | +35.57% |
| 2014-12-31 | €9.88 Billion | €711.22 Million | 0.072x | -9.41% |
| 2013-12-31 | €9.06 Billion | €720.17 Million | 0.079x | -- |